(AGE) A.G.Edwards gets an $89.50 buyout from Wachovia (WB) in cash and stock.
(AGIX) AtheroGenics announces business plan to focus on advancing AGI-1067 in diabetes.
(ASML) ASML will return 960 million Euros to shareholders in combination with an 8 for 9 split.
(BLI) Big Lots $0.26 EPS vs $0.20e.
(BRCD) Brocade is paying a $7 million SEC fine to settle its options backdating issue.
(CIEN) Ciena $0.26 EPS vs $0.25e; sees revenues up 3% in Q3 and sees 2007 revenue growth up to 36% from prior range of 27% to 30%.
(CLF) Cleveland Cliffs noted as takeover candidate by Jim Cramer on Mad Money.
(CONN) Conn’s $0.54 EPS vs $0.48e.
(COST) CostCo $0.56 EPS vs $0.56e; R$14.66B vs $14.68B(e).
(CRTX) Critical Therapeutics says FDA approves it’s ANDA for a twice-daily Zyflo CR extended-release tablets for asthma.
(FMX) FEMSA trades ex-split today to reflect its 3 for 1 stock split.
(HRAY) Hurray CFO/Co-Founder Jesse Liu will resign from his management role in the company at Hurray Holding.
(JTX) Jackson Hewitt $2.04 EPS vs. $1.93 estimate.
(LAYN) Layne Christensen $0.52 EPS vs $0.37e; unsure if comparable.
(MEDX) Medarex announced collaborative research pact with Mitsubishi Pharma.
(MGRM) Monogram announced it will release data on its biomarkers for breast cancer at ASCO.
(MOT) Motorola announced 4,000 layoffs in what is turning into an 11-yearrestructuring plan.
(MYL) Mylan Labs announced tentative FDA approval for its ANDA of paroxetine hydrochloride extended-release tablets.
(NOVL) Novell traded up 3% after beating earnings expectations.
(NRG) NRG Energy trades ex-split Tomorrow (Friday) and will reflect its 2 for 1 split then.
(VSEA) Varian Semi trades ex-split to reflect its 3 for 2 stock split today.
(WLP) (WLP) WellPoint CFO is resigning due to code of conduct violations
(WYE) Wyeth received FDA approval for its mTOR inhibitor for advanced kidney cancer.
Jon C. Ogg
May 31, 2007
Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
